Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anand Date

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|November 29, 2012
Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couplesSomya Gupta, Reuben Granich, Amitabh B Suthar, et al.
Plos One|December 23, 2017
Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assayTefera Agizew, Joyce Basotli, Heather Alexander, et al.
Journal of the International AIDS Society|October 29, 2021
Tuberculosis treatment within differentiated service delivery models in global HIV/TB programmingCuc H Tran, Brittany K Moore, Ishani Pathmanathan, et al.
BMC Infectious Diseases|October 27, 2016
Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortalityAndrew F Auld, Tefera Agizew, Sherri Pals, et al.
MMWR. Morbidity and Mortality Weekly Report|March 21, 2024
Tuberculosis Preventive Treatment Update - U.S. President's Emergency Plan for AIDS Relief, 36 Countries, 2016-2023Aderonke S Ajiboye, Stephanie O'Connor, Jonathan P Smith, et al.
Plos One|August 18, 2017
Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in BotswanaTefera Agizew, Rosanna Boyd, Ndwapi Ndwapi, et al.
Emerging Infectious Diseases|March 21, 2026
Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020-2024Minal Ahson, Daksha Shah, Sampada Bhide, et al.
Digestive Diseases and Sciences|February 27, 2008
Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjectsHassan Ashktorab, Hassan Brim, Marwa Al-Riyami, et al.
JMIR Public Health and Surveillance|April 30, 2021
Collect Once, Use Many Times: Attaining Unified Metrics for Tuberculosis Preventive Treatment for People Living With HIVRena Fukunaga, David Lowrance, Adam MacNeil, et al.
AIDS (London, England)|September 27, 2023
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS ReliefMeaghan Peterson, Rebeca Briceno-Robaugh, Stephanie O'Connor, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes (1999)|November 29, 2012
Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couplesSomya Gupta, Reuben Granich, Amitabh B Suthar, et al.
Plos One|December 23, 2017
Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assayTefera Agizew, Joyce Basotli, Heather Alexander, et al.
Journal of the International AIDS Society|October 29, 2021
Tuberculosis treatment within differentiated service delivery models in global HIV/TB programmingCuc H Tran, Brittany K Moore, Ishani Pathmanathan, et al.
BMC Infectious Diseases|October 27, 2016
Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortalityAndrew F Auld, Tefera Agizew, Sherri Pals, et al.
MMWR. Morbidity and Mortality Weekly Report|March 21, 2024
Tuberculosis Preventive Treatment Update - U.S. President's Emergency Plan for AIDS Relief, 36 Countries, 2016-2023Aderonke S Ajiboye, Stephanie O'Connor, Jonathan P Smith, et al.
Plos One|August 18, 2017
Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in BotswanaTefera Agizew, Rosanna Boyd, Ndwapi Ndwapi, et al.
Emerging Infectious Diseases|March 21, 2026
Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020-2024Minal Ahson, Daksha Shah, Sampada Bhide, et al.
Digestive Diseases and Sciences|February 27, 2008
Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjectsHassan Ashktorab, Hassan Brim, Marwa Al-Riyami, et al.
JMIR Public Health and Surveillance|April 30, 2021
Collect Once, Use Many Times: Attaining Unified Metrics for Tuberculosis Preventive Treatment for People Living With HIVRena Fukunaga, David Lowrance, Adam MacNeil, et al.
AIDS (London, England)|September 27, 2023
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS ReliefMeaghan Peterson, Rebeca Briceno-Robaugh, Stephanie O'Connor, et al.
Pageof 4